InVivo Therapeutics Holdings Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.57 | $1.57 | $1.57 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
InVivo Therapeutics Holdings Corp. Earnings Date And Information
InVivo Therapeutics Holdings Corp. last posted its earnings results on Thursday, February 20th, 2020. The company reported $-199.5 earnings per share for the quarter, topping analysts' consensus estimates of $-225 by $25.5. The company had revenue of 0 for the quarter and had revenue of 0 for the year. InVivo Therapeutics Holdings Corp. has generated $-7 earnings per share over the last year ($-6.62 diluted earnings per share) and currently has a price-to-earnings ratio of -0.21. InVivo Therapeutics Holdings Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based on prior year's report dates.
InVivo Therapeutics Holdings Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2023 | Q3 2023 | -$0.87 | $0 | $0 | ||
| 08/09/2023 | Q2 2023 | -$0.62 | $0 | $0 | ||
| 05/12/2023 | Q1 2023 | -$0.80 | $0 | |||
| 03/01/2023 | Q4 2022 | -$1.41 | $0 | |||
| 11/07/2022 | Q3 2022 | -$1.92 | $0 | |||
| 08/08/2022 | Q2 2022 | -$1.95 | $0 | |||
| 05/10/2022 | Q1 2022 | -$1.93 | $0 | |||
| 03/07/2022 | Q4 2021 | -$2.12 | $0 | |||
| 11/10/2021 | Q3 2021 | -$1.79 | $0 | |||
| 08/13/2021 | Q2 2021 | -$1.68 | $0 | |||
| 05/10/2021 | Q1 2021 | -$1.89 | $0 | |||
| 03/01/2021 | Q4 2020 | -$11.24 | $0 | |||
| 11/06/2020 | Q3 2020 | -$11.69 | $0 | |||
| 08/11/2020 | Q2 2020 | -$12.29 | $0 | |||
| 05/13/2020 | Q1 2020 | -$61.83 | $0 | |||
| 02/20/2020 | Q4 2019 | -$225.00 | -$86.36 | 138.64 | $0 | |
| 11/07/2019 | Q3 2019 | -$9.90 | -$215.79 | -205.89 | $0 | |
| 08/13/2019 | Q2 2019 | -$9.30 | -$253.24 | -243.94 | $0 | |
| 05/10/2019 | Q1 2019 | -$8.70 | -$212.28 | -203.58 | $0 | |
| 04/01/2019 | Q4 2018 | -$203.40 | $0 |
InVivo Therapeutics Holdings Corp. Earnings: Frequently Asked Questions
-
When is InVivo Therapeutics Holdings Corp.'s earnings date?
InVivo Therapeutics Holdings Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates.
-
Did InVivo Therapeutics Holdings Corp. beat their earnings estimates last quarter?
In the previous quarter, InVivo Therapeutics Holdings Corp. (:NVIV) reported $-199.5 earnings per share (EPS) to beat the analysts' consensus estimate of $-225 by $25.5.
-
How can I listen to InVivo Therapeutics Holdings Corp.'s earnings conference call?
The conference call for InVivo Therapeutics Holdings Corp.'s latest earnings report can be listened to online.
-
How can I read InVivo Therapeutics Holdings Corp.'s conference call transcript?
The conference call transcript for InVivo Therapeutics Holdings Corp.'s latest earnings report can be read online.
-
How much profit does InVivo Therapeutics Holdings Corp. generate each year?
InVivo Therapeutics Holdings Corp. (:NVIV) has a recorded net income of $0. InVivo Therapeutics Holdings Corp. has generated $-6.62 earnings per share over the last four quarters.
-
What is InVivo Therapeutics Holdings Corp.'s price-to-earnings ratio?
InVivo Therapeutics Holdings Corp. (:NVIV) has a price-to-earnings ratio of -0.21 and price/earnings-to-growth ratio is -0.01.
